XML 17 R7.htm IDEA: XBRL DOCUMENT v3.24.3
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
$ in Thousands
6 Months Ended 9 Months Ended
Jun. 29, 2024
USD ($)
Sep. 28, 2024
USD ($)
Sep. 30, 2023
USD ($)
Net Cash Provided by (Used in) Operating Activities, Continuing Operations [Abstract]      
Net income   $ 59,909 $ 6,541
Adjustments to reconcile net income to net cash provided by operating activities:      
Depreciation   22,197 22,880
Amortization   1,920 6,043
Reduction in the carrying amount of right-of-use assets   5,129 5,556
Stock-based compensation expense   29,550 29,333
Deferred income tax benefit   (14,044) (6,283)
Provision for excess and obsolete inventories   10,052 12,566
Gain on sale of business   (20,581) 0
Other adjustments to reconcile net income to net cash provided by operating activities   (2,178) 1,375
Changes in assets and liabilities:      
Accounts receivable   (13,300) (7,796)
Inventories   (7,573) (8,910)
Prepaid expenses and other current assets   (256) (1,761)
Other assets   295 804
Accounts payable   (8,780) 474
Accrued liabilities   7,368 (5,268)
Other liabilities   9,331 467
Deferred revenues   7,883 (12,915)
Deferred grant $ 18,000 0  
Operating lease liabilities   (5,301) (5,754)
Net cash provided by operating activities   81,621 55,352
Net Cash Provided by (Used in) Investing Activities, Continuing Operations [Abstract]      
Acquisition of property, plant and equipment   (30,773) (46,094)
Proceeds from sale of business   21,585 0
Purchases of marketable securities   (109,727) (96,913)
Purchase of promissory note receivable   (1,500) 0
Proceeds from maturities and sales of marketable securities   94,263 93,013
Net cash used in investing activities   (26,152) (49,994)
Cash flows from financing activities:      
Proceeds from issuances of common stock   9,748 8,822
Purchase of common stock through stock repurchase program   (37,211) 0
Tax withholdings related to net share settlements of equity awards   (17,990) (9,349)
Payments on term loan   (803) (781)
Net cash used in financing activities   (46,256) (1,308)
Effect of exchange rate changes on cash, cash equivalents and restricted cash   3 (3,324)
Net increase in cash, cash equivalents and restricted cash   9,216 726
Cash, cash equivalents and restricted cash, beginning of year $ 181,273 181,273 112,982
Cash, cash equivalents and restricted cash, end of period   190,489 113,708
Non-cash investing and financing activities:      
Decrease in accounts payable and accrued liabilities related to property, plant and equipment purchases   2,915 6,222
Operating lease, right-of-use assets obtained in exchange for lease obligations   0 4,728
Supplemental disclosure of cash flow information:      
Cash paid for income taxes, net   13,114 12,064
Cash paid for interest   298 317
Operating cash outflows from operating leases   6,960 6,836
Reconciliation of cash, cash equivalents and restricted cash:      
Cash and cash equivalents   184,506 108,731
Restricted cash, current   3,773 1,171
Restricted cash   2,210 2,146
Cash and cash equivalents included in Assets held-for-sale   0 1,660
Total cash, cash equivalents and restricted cash   $ 190,489 $ 113,708